AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Chassevent, A Jourdan, ML Romain, S Descotes, F Colonna, M Martin, PM Bolla, M Spyratos, F
Citation: A. Chassevent et al., S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: A standardizedflow cytometric study, CLIN CANC R, 7(4), 2001, pp. 909-917

Authors: Broet, P Romain, S Daver, A Ricolleau, G Quillien, V Rallet, A Asselain, B Martin, PM Spyratos, F
Citation: P. Broet et al., Thymidine kinase as a proliferative marker: Clinical relevance in 1,692 primary breast cancer patients, J CL ONCOL, 19(11), 2001, pp. 2778-2787

Authors: Bagwell, CB Clark, GM Spyratos, F Chassevent, A Bendahl, PO Stal, O Killander, D Jourdan, ML Romain, S Hunsberger, B Baldetorp, B
Citation: Cb. Bagwell et al., Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens, CYTOMETRY, 46(3), 2001, pp. 121-135

Authors: Romain, S Bendahl, PO Guirou, O Malmstrom, P Martin, PM Ferno, M
Citation: S. Romain et al., DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients, INT J CANC, 95(1), 2001, pp. 56-61

Authors: Foekens, JA Romain, S Look, MP Martin, PM Klijn, JGM
Citation: Ja. Foekens et al., Thymidine kinase and thymidylate synthase in advanced breast cancer: Response to tamoxifen and chemotherapy, CANCER RES, 61(4), 2001, pp. 1421-1425

Authors: Fina, F Romain, S Ouafik, LH Palmari, J Ben Ayed, F Benharkat, S Bonnier, P Spyratos, F Foekens, JA Rose, C
Citation: F. Fina et al., Frequency and genome load of Epstein-Barr virus in 509 breast cancers fromdifferent geographical areas, BR J CANC, 84(6), 2001, pp. 783-790

Authors: Span, P Heuvel, J Romain, S Piffanelli, A Martin, PM Geurts-Moespot, A Sweep, F
Citation: P. Span et al., EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols, ANTICANC R, 20(2A), 2000, pp. 681-687

Authors: Romain, S Spyratos, F Descotes, F Daver, A Rostaing-Puissant, B Bougnoux, P Colonna, M Bolla, M Martin, PM
Citation: S. Romain et al., Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: A retrospective multicenter study, INT J CANC, 87(6), 2000, pp. 860-868

Authors: Spyratos, F Romain, S Rostaing-Puissant, B Daver, A Colonna, M Descotes, F Martin, PM Bougnoux, P Roth, H Bolla, M
Citation: F. Spyratos et al., Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study 1. DNA synthesis enzyme activities, B CANCER, 86(7-8), 1999, pp. 678-684

Authors: Chassevent, A Jourdan, ML Ferrero-Pous, M Colonna, M Romain, S Spyratos, F Roth, H Bolla, M
Citation: A. Chassevent et al., Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction, B CANCER, 86(7-8), 1999, pp. 685-691

Authors: Broet, P Spyratos, F Romain, S Quillien, V Daver, A Ricolleau, G Rallet, A Toulas, C Asselain, B
Citation: P. Broet et al., Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study, BR J CANC, 80(3-4), 1999, pp. 536-545
Risultati: 1-11 |